The global medical robotic systems market size was valued at USD 21.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 16.9% from 2023 to 2030. Due to pathological and psychological changes that occur with age, the geriatric population is more common to injuries and other medical conditions that will require surgical procedures. The rising demand for accurate laparoscopic surgeries and the increasing percentage of trauma injuries are the key factors propelling the market growth. Furthermore, growing technological advancement in medical equipment and a rise in per capita healthcare spending are projected to drive the market in emerging economies.
Continuous technological advancements such as motion sensors, robotic catheter control systems (CCS), 3D-Imaging, data recorders, data analytics, HD surgical microscopic cameras, and remote navigation are expected to fuel market growth. In addition, increasing FDA clearances for products are expected to propel market growth in the forecast period. For instance, ReWalk Robotics proclaimed that the FDA had authorized the sale of its ReStore soft exo-suit system to rehabilitation centers throughout the U.S. in 2019.
Globally, there is a surge in the demand for robotic minimally invasive surgeries majorly due to advantages related to the procedures, such as lesser cuts, smaller incisions, reduced pain, decreased scarring, higher safety, and quicker recovery periods. Moreover, the procedures offer highly advanced visualization capabilities to the surgeons by using HD cameras to illustrate microscopic structures. Thus, providing greater control and ensuring higher accuracy. In the past few years, there is a rise in the number of research into rehabilitation robotics and a rapid surge in the number of therapeutic rehabilitation robots.
The developing countries are projected to offer noteworthy opportunities for players in the market. During the past decade, emerging regions have witnessed a persistent surge in the percentage of surgical procedures, driven by the increasing target patient population and growing medical tourism. Furthermore, growing healthcare expenditure along with adaptive and business-friendly regulatory strategies are encouraging key players to focus more on emerging markets in the future.
One of the major challenges expected to restrain the market growth is the high price of robotic systems. Robot-assisted procedures are more expensive than other surgeries. The most commonly used robotic system, the da Vinci system, costs between USD 1.0 million and USD 3.0 million, whereas the cost of the CyberKnife radiosurgery robotic system ranges from USD 4.2 to 5.2 million per unit. Furthermore, an additional USD 100,000 is required for maintenance. Thus, the rising cost of surgeries due to the adoption of the robotic system is expected to hamper the market growth.
Like other industries, COVID has also hampered the growth of the market for medical robotic systems. The pandemic has led to a provisional ban on elective surgeries throughout the world, which resulted in withdrawals of elective surgeries. As per the report of the World Economic Forum, during the pandemic, about 28 million elective surgeries were canceled in 12 weeks. About 38% of the global cancer surgeries were stopped. Moreover, COVID-19 caused economic disruption throughout the world, which further badly affected the market growth. However, the market is expected to recover soon and the adoption of medical robots can be expected to be back to pre-covid levels.
The medical service robots segment dominated the market for medical robotic systems and accounted for a revenue share of over 69.3% in 2022. The medical service robots help to improve the level of patient care by assisting the medical staff and providing operational efficiencies. In addition, they help to combat the labor shortage and minimize human error. Moreover, the service robots played a crucial role in fighting the coronavirus healthcare crisis. Furthermore, various robots being developed by key players are impelling the segment growth. For instance, Aethon’s TUG autonomous mobile robot is used to deliver medications, laboratory specimens, and other sensitive material within a hospital environment.
The cleanroom robots segment is anticipated to grow at the fastest rate during the forecast period owing to its advantages such as flexibility and cost and time reduction. In addition, they can be reprogrammed in case an application or container formats change. In addition, they help to minimize or eliminate the contamination, thereby preventing hospital-acquired infections. Moreover, the outbreak of COVID-19 raised the demand for cleanroom robots to reduce the spread of the virus among patients, staff, and doctors.
Asia Pacific held the largest revenue share of over 52.8% in 2022. The increasing geriatric population with weak bone density levels and injuries encountered during accidents is expected to positively reinforce market growth in the coming years. The presence of emerging opportunities, improving healthcare infrastructure, penetration of minimally invasive surgeries, and rising patient awareness are the key factors that are expected to fuel the market growth in the Asia Pacific region. With automation becoming central to pharmaceutical manufacturing, maintaining higher levels of accuracy, and minimizing workload, robotics offers the next wave of transformation. Gilead Sciences, a Fortune 500 company, exhibited the high growth potential of the global pharmaceutical industry through its 5-year revenue growth rate of 28.8%. This is expected to increase the need for pharmaceutical robotics to automate tasks and minimize work pressure generated by such growing companies.
The implementation of advanced technologies such as developed software, imaging systems, and capsule robot systems to reduce the complications in surgical interventions is expected to further boost the market growth over the forecast period. The major product segments contributing to the growth of Asia Pacific include products such as surgical robots and non-invasive radiosurgery systems. Japan, Singapore, Thailand, South Korea, and China are joining hands to buy an increasing amount of robotics systems from abroad, and are also focusing on developing medical robotics technologies themselves. For instance, the Chinese Government has supported more than 30 Medtech manufacturers to develop robotic medical devices, surgical robots, and intelligent robots. SS Innovations, a Chinese robotics company, in Huizhou is building and testing an inexpensive, modular robotic surgical system, which is capable of controlling complex motion.
The key participants in the market are devising various strategic initiatives to expand their business footprint and gain a competitive edge in the market. Key players are focusing on strategic initiatives such as mergers & acquisitions, collaborations, partnerships, funding and investments, and innovative product developments and launches to expand their expertise and product portfolio. For instance, in June 2020, Accuray introduced its next-generation CyberKnife platform called the CyberKnife S7 System with advanced precision and real-time AI-driven motion tracking and synchronization treatment delivery for all stereotactic body radiation therapy (SBRT) treatments and stereotactic radiosurgery (SRS). Some prominent players in the global medical robotic systems market include:
Titan Medical Inc.
Health Robotics SLR
OR Productivity plc
Mako Surgical Corp.
Varian Medical Systems
Smith & Nephew
Market size value in 2023
USD 25.6 billion
Revenue forecast in 2030
USD 76.4 billion
CAGR of 16.9% from 2023 to 2030
Base year for estimation
2017 - 2021
2023 - 2030
Revenue in USD Million and CAGR from 2023 to 2030
Revenue forecast, company share, competitive landscape, growth factors & trends
Type, end-user and region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; India; Japan; Australia; South Korea; Singapore; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE
Key companies profiled
iRobot Corporation; Medrobotics Corporation; Titan Medical Inc.; Hansen; Renishaw Plc; Intuitive Surgical; Health Robotics SLR; OR Productivity plc; Mazor Robotics; Accuray; Mako Surgical Corp.; Varian Medical Systems; Stereotaxis Inc., Medtronic, Stryker, Zimmer Biomet, Smith & Nephew
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research, Inc. has segmented the global medical robotic systems market report based on type end-user and region:
Type Outlook (Revenue, USD Million, 2017 - 2030)
Surgical Robots, By Application
Exo-robots, By Extremities
Medical Service Robots
End User Outlook (Revenue, USD Million, 2017 - 2030)
Ambulatory Surgery Centers
Regional Outlook (Revenue, USD Million, 2017 - 2030)
b. The global medical robotic systems market size was estimated at USD 21.2 billion in 2022 and is expected to reach USD 25.6 billion in 2023.
b. The global medical robotic systems market is expected to grow at a compound annual growth rate of 16.9% from 2023 to 2030 to reach USD 76.4 billion by 2030.
b. Medical service robots dominated the medical robotic systems market with a share of 69.3% in 2022. This is attributable to widespread adoption during the ongoing pandemic in disinfecting care facilities and treatment units.
b. Some key players operating in the medical robotic systems market include MAKO Surgical Corp.; Reninshaw Plc.; Varian, Accuray; Intuitive Surgical Inc.; and Health robotics S.R.L.
b. Key factors that are driving the medical robotic systems market growth include increasing demand for accurate laparoscopic surgeries, growing need for surgical procedures in the geriatric population, and rising cases of trauma injuries.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."